Per-Protocol and Pre-Defined population analysis of the LINC study - Resuscitation
Clinical Trials analysis Endpoints planned and unplanned secondary
AUTH/2607/5/13 - Pfizer v GlaxoSmithKline
Efficacy and tolerability of racecadotril in acute diarrhea in children - Gastroenterology
Results - Clinical Review Report: Ocrelizumab (Ocrevus) - NCBI Bookshelf
CONSORT diagram. Composition of the per protocol population with sleep... | Download Scientific Diagram
Discordance between reported intention-to-treat and per protocol analyses - Journal of Clinical Epidemiology
Supplemental Materials for Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study - European Journal of Cancer
IN THE PER PROTOCOL POPULATION ▷ Tradução em Português - Exemplos De Uso Numa Sentença Em Inglês
PLOS Medicine: Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Change from baseline in trough forced expiratory volume in 1 s (FEV1) (per-protocol population). Change from baseline in trough forced expiratory volume. - ppt download
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
1745-6215-14-371-S1
MAVYRET Efficacy and Clinical Study Designs
1 PROTECT II Prospective Multicenter Randomized Trial Comparing
Randomized, Double Blind and Placebo Controlled Study Using a Combination of Two Probiotic Lactobacilli to Alleviate Symptoms and Frequency of Common Cold
Amlodipine Besylate Vs. Candesartan Cilexetil
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
View Image
Causal Inference from Pragmatic Trials.
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial - Clinical Microbiology and Infection
